scholarly article | Q13442814 |
P50 | author | Steve Sussman | Q58065844 |
Adam M. Leventhal | Q89930183 | ||
P2093 | author name string | Christopher W Kahler | |
Jennifer W Tidey | |||
Katherine J Ameringer | |||
Michael Trujillo | |||
P2860 | cites work | Dopamine and reward: The anhedonia hypothesis 30 years on | Q22252806 |
Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication | Q22253031 | ||
Enhancing research and treatment of mental disorders with dimensional concepts: toward DSM-V and ICD-11 | Q24643497 | ||
Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II | Q28260514 | ||
The other face of depression, reduced positive affect: the role of catecholamines in causation and cure | Q28269179 | ||
The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire | Q29615435 | ||
Anxiety sensitivity and anxiety and depressive symptoms in the prediction of early smoking lapse and relapse during smoking cessation treatment | Q30486877 | ||
Distribution of the product confidence limits for the indirect effect: program PRODCLIN | Q33303721 | ||
Modeling the effect of alcohol on smoking lapse behavior | Q33821440 | ||
Delay discounting and future-directed thinking in anhedonic individuals | Q33823220 | ||
On the specificity of positive emotional dysfunction in psychopathology: evidence from the mood and anxiety disorders and schizophrenia/schizotypy | Q33936901 | ||
Anhedonia, depressed mood, and smoking cessation outcome | Q37603411 | ||
Positive Psychotherapy for Smoking Cessation: Treatment Development, Feasibility and Preliminary Results | Q37661486 | ||
Borderline personality disorder: a dysregulation of the endogenous opioid system? | Q37741217 | ||
The state-trait disjunction of anhedonia in schizophrenia: potential affective, cognitive and social-based mechanisms | Q37815813 | ||
Neural substrates of psychostimulant withdrawal-induced anhedonia | Q37821389 | ||
Positive and negative affect as predictors of urge to smoke: temporal factors and mediational pathways | Q39230539 | ||
Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings | Q39420790 | ||
Probing brain reward system function in major depressive disorder: altered response to dextroamphetamine | Q40643565 | ||
Anhedonia: a neglected symptom of psychopathology. | Q40728395 | ||
Vulnerability to depression: a model centered on anhedonia | Q41236036 | ||
Anhedonia and substance dependence: clinical correlates and treatment options. | Q42728896 | ||
Biochemical verification of tobacco use and cessation | Q44005083 | ||
Hedonic capacity, cigarette craving, and diminished positive mood. | Q44775899 | ||
Anhedonia and emotional numbing in combat veterans with PTSD. | Q45332860 | ||
Impulsivity and the reinforcing value of cigarette smoking | Q48448246 | ||
Diagnosing major depressive disorder I: A psychometric evaluation of the DSM-IV symptom criteria | Q48509379 | ||
Reward value of cigarette smoking for comparably heavy smoking schizophrenic, depressed, and nonpatient smokers | Q48606772 | ||
Symptoms of depression and survival experience among three samples of smokers trying to quit | Q48684067 | ||
Signs and symptoms of tobacco withdrawal | Q49016637 | ||
The nature of diminished pleasure in individuals at risk for or affected by schizophrenia. | Q50616023 | ||
Development and validation of a 30-item short adaptation of the Mood and Anxiety Symptoms Questionnaire (MASQ). | Q50692637 | ||
Influence of nicotine on positive affect in anhedonic smokers. | Q50910925 | ||
The early time course of smoking withdrawal effects. | Q50935985 | ||
EEG, physiology, and task-related mood fail to resolve across 31 days of smoking abstinence: relations to depressive traits, nicotine exposure, and dependence. | Q51083908 | ||
The effect of stress on hedonic capacity. | Q51140730 | ||
The assessment of anhedonia in clinical and non-clinical populations: further validation of the Snaith-Hamilton Pleasure Scale (SHAPS). | Q51912347 | ||
Correlates of psychosis proneness in relatives of schizophrenic patients | Q63387587 | ||
A comparison of homeless, community-wide, and selected distressed samples on the CES-Depression Scale | Q68603008 | ||
Mood disturbance fails to resolve across 31 days of cigarette abstinence in women | Q77674722 | ||
[Validation of the Temporal Experience of Pleasure Scale (TEPS) in a French-speaking environment] | Q84091711 | ||
A new perspective on anhedonia in schizophrenia | Q95783803 | ||
Reconsidering anhedonia in depression: lessons from translational neuroscience | Q34124371 | ||
Effects of anhedonia on days to relapse among smokers with a history of depression: a brief report | Q34169592 | ||
Models for longitudinal data: a generalized estimating equation approach | Q34170659 | ||
Effects of smoking abstinence, smoking cues and nicotine replacement in smokers with schizophrenia and controls | Q34186224 | ||
Primary and secondary hypohedonia | Q34191205 | ||
The drug abuse screening test | Q34280814 | ||
Explaining the covariance between attention-deficit hyperactivity disorder symptoms and depressive symptoms: the role of hedonic responsivity. | Q34337924 | ||
Applying the tripartite model of anxiety and depression to cigarette smoking: an integrative review | Q34349422 | ||
Meta-analysis of the factor structures of four depression questionnaires: Beck, CES-D, Hamilton, and Zung | Q34467494 | ||
Reference values for generic instruments used in routine outcome monitoring: the Leiden Routine Outcome Monitoring Study | Q34484522 | ||
Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe | Q34562417 | ||
The center for epidemiologic studies depression scale: a review with a theoretical and empirical examination of item content and factor structure | Q34613399 | ||
Randomized controlled trial of behavioral activation smoking cessation treatment for smokers with elevated depressive symptoms | Q34616162 | ||
Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression | Q34618440 | ||
Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure | Q34626865 | ||
Anticipatory vs. consummatory pleasure: what is the nature of hedonic deficits in schizophrenia? | Q34762414 | ||
Nicotine and food deprivation decrease the ability to resist smoking | Q35035989 | ||
A quantitative analysis of subjective, cognitive, and physiological manifestations of the acute tobacco abstinence syndrome | Q35148815 | ||
Addiction motivation reformulated: an affective processing model of negative reinforcement | Q35645919 | ||
Distress tolerance and early smoking lapse | Q35728521 | ||
Developing and validating a human laboratory model to screen medications for smoking cessation | Q36349950 | ||
Acute stress reduces reward responsiveness: implications for depression | Q36528694 | ||
Should criteria for drug dependence differ across drugs? | Q36575886 | ||
Social support and well-being at mid-life among mothers of adolescents and adults with autism spectrum disorders | Q36679825 | ||
Comparison of major depressive disorder and subthreshold depression among older adults in community long-term care | Q36707495 | ||
Toward an objective characterization of an anhedonic phenotype: a signal-detection approach | Q36749689 | ||
Stress decreases the ability to resist smoking and potentiates smoking intensity and reward | Q36798820 | ||
Cigarette demand and delayed reward discounting in nicotine-dependent individuals with schizophrenia and controls: an initial study | Q36807511 | ||
Refining the depression-nicotine dependence link: patterns of depressive symptoms in psychiatric outpatients with current, past, and no history of nicotine dependence | Q37112018 | ||
Gender differences in acute tobacco withdrawal: effects on subjective, cognitive, and physiological measures | Q37116361 | ||
Dimensions of depressive symptoms and smoking cessation | Q37116365 | ||
Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications | Q37382948 | ||
Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans | Q37485527 | ||
An efficient early phase 2 procedure to screen medications for efficacy in smoking cessation | Q37543473 | ||
P433 | issue | 2 | |
P921 | main subject | anhedonia | Q545365 |
P304 | page(s) | 375-386 | |
P577 | publication date | 2014-05-01 | |
P1433 | published in | Journal of Abnormal Psychology | Q6294719 |
P1476 | title | Anhedonia and the relative reward value of drug and nondrug reinforcers in cigarette smokers | |
P478 | volume | 123 |
Q45068179 | 21st century neurobehavioral theories of decision making in addiction: Review and evaluation. |
Q42723800 | A behavioral economic perspective on smoking persistence in serious mental illness |
Q92617412 | Addiction, Anhedonia, and Comorbid Mood Disorder. A Narrative Review |
Q90573488 | Adolescent and adult nicotine exposure differentially impacts oral nicotine and oral saccharin self-administration in mice |
Q46074600 | Anhedonia and Abstinence as Predictors of the Subjective Pleasantness of Positive, Negative, and Smoking-Related Pictures. |
Q90488502 | Anhedonia and smoking cessation among Spanish-speaking Mexican-Americans |
Q93207279 | Anhedonia as a phenotypic marker of familial transmission of polysubstance use trajectories across midadolescence |
Q34021889 | Anxiety sensitivity as an amplifier of subjective and behavioral tobacco abstinence effects |
Q34945464 | Anxiety, depression, and cigarette smoking: a transdiagnostic vulnerability framework to understanding emotion-smoking comorbidity |
Q47707303 | Cigarette demand among smokers with elevated depressive symptoms: an experimental comparison with low depressive symptoms |
Q38954406 | Cigarette smoking and depression comorbidity: systematic review and proposed theoretical model |
Q30401556 | Current major depression is associated with greater sensitivity to the motivational effect of both negative mood induction and abstinence on tobacco-seeking behavior |
Q47425419 | Depressive Symptoms and Cigarette Demand as a Function of Induced Stress |
Q89149072 | Gender Differences in Negative Affect During Acute Tobacco Abstinence Differ Between African American and White Adult Cigarette Smokers |
Q36817011 | Gender differences in negative reinforcement smoking expectancies |
Q36883416 | Gender, Ethnicity, and Their Intersectionality in the Prediction of Smoking Outcome Expectancies in Regular Cigarette Smokers |
Q39692543 | Is the Effect of Anhedonia on Smoking Cessation Greater for Women Versus Men? |
Q41911418 | Longitudinal changes in smoking abstinence symptoms and alternative reinforcers predict long-term smoking cessation outcomes |
Q35946885 | Negative mood reverses devaluation of goal-directed drug-seeking favouring an incentive learning account of drug dependence |
Q38786496 | Neural correlates of RDoC reward constructs in adolescents with diverse psychiatric symptoms: A Reward Flanker Task pilot study |
Q45295167 | Obsessive-compulsive symptoms and negative affect during tobacco withdrawal in a non-clinical sample of African American smokers |
Q90439301 | Possible New Symptoms of Tobacco Withdrawal III: Reduced Positive Affect-A Review and Meta-analysis |
Q35316586 | Post-traumatic stress disorder symptoms, underlying affective vulnerabilities, and smoking for affect regulation |
Q35532120 | Psychological symptoms, smoking lapse behavior, and the mediating effects of nicotine withdrawal symptoms: A laboratory study |
Q39023725 | Second Generation Electronic Nicotine Delivery System Vape Pen Exposure Generalizes as a Smoking Cue. |
Q92539755 | Sensitivity of hypothetical purchase task indices when studying substance use: A systematic literature review |
Q35531227 | Shared versus specific features of psychological symptoms and cigarettes per day: structural relations and mediation by negative- and positive-reinforcement smoking |
Q35531529 | Smoking-related correlates of psychomotor restlessness and agitation in a community sample of daily cigarette smokers |
Q34736710 | Socioeconomic status and the reward value of smoking following tobacco abstinence: a laboratory study |
Q38608641 | The Role of Depression in the Uptake and Maintenance of Cigarette Smoking |
Q38428284 | The Sociopharmacology of Tobacco Addiction: Implications for Understanding Health Disparities |
Q46078519 | Tobacco Withdrawal Amongst African American, Hispanic, and White Smokers |
Q36070186 | Tobacco withdrawal symptoms mediate motivation to reinstate smoking during abstinence |
Search more.